Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Lymphoma 215Precursor Cell Lymphoblastic Leukemia-Lymphoma 188Lymphoma, Large B-Cell, Diffuse 172Leukemia 102Burkitt Lymphoma 91Lymphoma, Non-Hodgkin 89Lymphoma, Follicular 78Lymphoma, Mantle-Cell 53Neuroblastoma 51Hodgkin Disease 46Central Nervous System Neoplasms 42Sarcoma 37Lymphoma, B-Cell 31Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 30Lymphoma, Large-Cell, Anaplastic 29Recurrence 28Lymphoma, T-Cell, Peripheral 28Lymphoma, Large-Cell, Immunoblastic 27Rhabdomyosarcoma 25Neoplasms 25Multiple Myeloma 24Medulloblastoma 22Lymphoma, B-Cell, Marginal Zone 22Leukemia, Lymphocytic, Chronic, B-Cell 21Leukemia, Biphenotypic, Acute 21Brain Neoplasms 20Sarcoma, Ewing 18Retinoblastoma 18Lymphoma, T-Cell 17HIV Infections 17

Interventions

liposomal doxorubicin 1Vincristine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Unrecognized Condition × Vincristine × Clear all
NCT04213612 2019-12-30

DCV in the Treatment of Recurrence and Refractory Childhood Solid Tumors

Sun Yat-sen University

Phase 1 Unknown
21 enrolled
Other neoplasm

Unrecognized Condition

Data powered by HemOnc (CC BY 4.0) Colophon âš¡